1. 1
Kantar Health covers the whole scope of Real World Research and Value
Real world
research and
value
Treatment
patterns
Patient
outcomes
Health
economics
Risk
managementEpidemiology
Unmet
needs
Using
Outcomes research
(SLR, MTC, meta-
analysis)
Real life studies,
NIS, Observational
studies, PRO
Primary data
Adhoc protocols
(OMT®)
Syndicated data
(NHWS®,
EpiDatabase®,
CancerMPact®,
PainMPact®)
• Treatment algorithms
• Patient pathways
• Duration of
treatment/dosage
• Drug utilization
• Identification of
gaps in disease
management
• For ALL
stakeholders:
physicians,
patients, payers,
pharmacists,
caregivers
• Size target
population
• Patient profiles
• Registries
• Bol/QoL
• PRO development
and validation
• Patient preference
• Patient adherence
• Patient satisfaction
• Resource utilization
(direct and indirect
costs)
• Economic
modelling (in
collaboration with
WG)
• PASS
• Pharmaco-
epidemiology
• Large cohort studies
• Registries
Claims and EHR
datasets (US,
Germany, Israel,
and Brazil)